Condition
Alveolar Rhabdomyosarcoma
Total Trials
4
Recruiting
1
Active
4
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
75%
3 trials in Phase 3/4
Results Transparency
0%
1 of 0 completed with results
Key Signals
1 with results
Data Visualizations
Phase Distribution
3Total
P 3 (3)
Trial Status
Active Not Recruiting3
Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT04994132Phase 3Active Not RecruitingPrimary
A Study to Compare Early Use of Vinorelbine and Maintenance Therapy for Patients With High Risk Rhabdomyosarcoma
NCT02567435Phase 3Active Not RecruitingPrimary
Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma
NCT03296371Active Not RecruitingPrimary
Genetic Mutational Analysis of Saliva or Buccal Mucosa Samples From Patients With Embryonal or Alveolar Rhabdomyosarcoma
NCT06669013Phase 3Recruiting
Chemo-immunotherapy in Patients Under 18 Years of Age With Bone and Soft Tissue Sarcomas
Showing all 4 trials